Beter Pharmaceutical R&D Building

Located in Chengdu, the Beter Pharmaceutical R&D Building serves as a dedicated research and development facility supporting advanced pharmaceutical innovation and drug development activities.

Completed in May 2022, the Beter Pharmaceutical R&D Building supports the research and development activities of Beter Pharmaceutical Co., Ltd., a high-tech enterprise specializing in pharmaceutical innovation, high-quality drug research, manufacturing, and commercialization.

With a research team of over 550 professionals, the company conducts full-cycle pharmaceutical research across multiple domains, including high-barrier active pharmaceutical ingredients, complex generic drugs and improved new formulations, as well as innovative therapies in gut microbiota and small nucleic acid drugs. The facility accommodates an integrated research ecosystem spanning intermediates, APIs, and finished dosage forms, providing a comprehensive platform for pharmaceutical innovation.